The New Injectable Treatment for Frown Lines

The FDA has approved a new anti-wrinkle injection that is taking the industry by storm. DAXXIFY™️ is an injectable treatment that blocks signals that cause muscles to contract and create wrinkles, creating smoother moderate to severe frown lines, crow’s feet, and other forehead lines. With this groundbreaking new treatment, you can enjoy longer-lasting results for treating forehead wrinkles with no downtime!

What is DAXXIFY™️?

DAXXIFY™️ is a part of a family of neuromodulators that use injections of a small amount of botulinum toxin to smooth wrinkles for a more youthful appearance. Like its predecessors, this new wrinkle treatment option works to relax the muscles responsible for the lines to create a natural, youthful look. What makes it even better is that by using DAXXIFY™️, you can actually save money because it lasts nearly double the amount of time than its competitors do.

Where on the Face Can Daxxify™️ Used?

During treatment, a small needle is used at the injection sites to apply the DAXXIFY™️ treatment as planned. Many patients report feeling nothing more than a minor pinch from the injection. However, we do provide numbing services upon request. Currently, DAXXIFY™️ is FDA approved to treat the following areas:

  • Frown Lines
  • Forehead Lines
  • Glabellar Lines (vertical lines in the eyebrows that resemble the number 11)

Because DAXXIFY™️ is a neuromodulator, it works by relaxing the muscles that form dynamic wrinkles. These wrinkles are caused by expressions we make every day,

Contact our Ava MD specialists today to schedule an appointment and get started on treating those forehead lines, so you can look and feel like yourself. We work with you to evaluate your individual needs and aesthetic goals.

How Is Daxxify™️ Different From Other Treatments, Like Botox?

DAXXIFY™️ lasts for up to 6 months (and in some cases 9!), making it the longest lasting injectable neuromodulator available on the aesthetic market. One reason it lasts so long is because thanks to the peptides found in its formula. DAXXIFY™️ is the first and only stabilized peptide-formulated neuromodulator on the market. The discovery of this formula is what stabilizes DAXXIFY™️ and contributes to its unique, long-lasting, and natural results.

Who is a Candidate for DAXXIFY™️

Ideal candidates are healthy, non-smoking patients over the age of 18 with realistic aesthetic goals. DAXXIFY™ is safe and effective for most adults and has been FDA approved to treat moderate to severe forehead lines. It performs well on various skin types and age groups, making it one of the best and most versatile treatment options available. Patients should consider the following factors:

  • Candidates cannot have skin infections or outbreaks
  • Candidates cannot pregnant or nursing
  • Candidates must be in good overall health
  • Candidates should have no history of neuromuscular disease
  • Candidates should have no allergies to the ingredients in Daxxify

At Ava MD, we stay on the cutting edge of aesthetic developments so we can ensure our patients receive the best, safest, and latest non-surgical treatments. Our specialists at Ava MD are happy to discuss whether DAXXIFY™️ is the right treatment for you during a free consultation.

DAXXIFY™️ Results You’ll Love

DAXXIFY™️ can deliver 6-9 month-long results with as few as two treatments, giving you time, convenience, and exceptionally long-lasting results. This formula has produced longer-lasting results in patients, preventing the muscles from forming wrinkles. While anti-wrinkle injection competitors like BOTOX®, Ceomin, Dysport, and Jeaveau last for about 3-4 months, DAXXIFY™️ has been shown in clinical trials to last as long as 6-9 months!


Contact Us

If you want to see if DAXXIFY™️ is right for you, give us a call. Our passionate team of physicians and aesthetic professionals are here to customize your treatment plan so you can enjoy gorgeous, long-lasting results. Give us a call, touch base with us online, or come visit us in Santa Monica and Beverly Hills.